The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D Molecular Therapeutics Inc | COM | 35104E100 | 6,314,206 | 198,186 | SH | SOLE | 198,186 | 0 | 0 | |||
Achieve Life Sciences Inc | COM | 004468500 | 6,900,355 | 1,518,230 | SH | SOLE | 1,518,230 | 0 | 0 | |||
Align Technology Inc | COM | 016255101 | 31,309,146 | 95,478 | SH | SOLE | 95,478 | 0 | 0 | |||
Alnylam Pharmaceuticals Inc | COM | 02043Q107 | 15,398,730 | 103,036 | SH | SOLE | 103,036 | 0 | 0 | |||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 871,110 | 306,729 | SH | SOLE | 306,729 | 0 | 0 | |||
Amylyx Pharmaceuticals Inc | COM | 03237H101 | 852,000 | 300,000 | SH | Put | SOLE | 300,000 | 0 | 0 | ||
Argenx SE | SPONSORED ADR | 04016X101 | 58,782,396 | 149,300 | SH | SOLE | 149,300 | 0 | 0 | |||
AstraZeneca PLC | SPONSORED ADR | 046353108 | 40,427,306 | 596,713 | SH | SOLE | 596,713 | 0 | 0 | |||
Avantor Inc | COM | 05352A100 | 5,943,644 | 232,446 | SH | SOLE | 232,446 | 0 | 0 | |||
Axonics Inc | COM | 05465P101 | 10,303,083 | 149,385 | SH | SOLE | 149,385 | 0 | 0 | |||
Baxter Intl Inc | COM | 071813109 | 854,800 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
Boston Scientific Corp | COM | 101137107 | 24,235,255 | 353,851 | SH | SOLE | 353,851 | 0 | 0 | |||
Cabaletta Bio Inc | COM | 12674W109 | 7,331,467 | 429,746 | SH | SOLE | 429,746 | 0 | 0 | |||
Celldex Therapeutics Inc | COM | 15117B202 | 33,650,581 | 801,777 | SH | SOLE | 801,777 | 0 | 0 | |||
Cogent Biosciences Inc | COM | 19240Q201 | 16,133,181 | 2,400,771 | SH | SOLE | 2,400,771 | 0 | 0 | |||
Cooper Cos Inc | COM | 216648501 | 2,154,605 | 21,236 | SH | SOLE | 21,236 | 0 | 0 | |||
Disc Medicine Inc | COM | 254604101 | 384,331 | 6,173 | SH | SOLE | 6,173 | 0 | 0 | |||
Dyne Therapeutics Inc | COM | 26818M108 | 54,981,494 | 1,936,650 | SH | SOLE | 1,936,650 | 0 | 0 | |||
Elanco Animal Health Inc | COM | 28414H103 | 41,604,305 | 2,555,547 | SH | SOLE | 2,555,547 | 0 | 0 | |||
Establishment Labs Hldgs Inc | COM | G31249108 | 7,185,146 | 141,162 | SH | SOLE | 141,162 | 0 | 0 | |||
Exact Sciences Corp | COM | 30063P105 | 15,847,958 | 229,481 | SH | SOLE | 229,481 | 0 | 0 | |||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 854,356 | 40,073 | SH | SOLE | 40,073 | 0 | 0 | |||
IDEAYA Biosciences Inc | COM | 45166A102 | 34,296,432 | 781,596 | SH | SOLE | 781,596 | 0 | 0 | |||
IDEXX Labs Inc | COM | 45168D104 | 40,615,694 | 75,224 | SH | SOLE | 75,224 | 0 | 0 | |||
Immatics NV | SHS | N44445109 | 22,739,919 | 2,163,646 | SH | SOLE | 2,163,646 | 0 | 0 | |||
Immatics NV | *W EXP 07/01/2025 | N44445117 | 853,059 | 316,349 | SH | SOLE | 316,349 | 0 | 0 | |||
Immunome Inc | COM | 45257U108 | 14,669,693 | 594,396 | SH | SOLE | 594,396 | 0 | 0 | |||
Inari Med Inc | COM | 45332Y109 | 490,164 | 10,216 | SH | SOLE | 10,216 | 0 | 0 | |||
Incyte Corp | COM | 45337C102 | 75,609,331 | 1,327,178 | SH | SOLE | 1,327,178 | 0 | 0 | |||
Inhibrx Inc | COM | 45720L107 | 45,540,469 | 1,302,645 | SH | SOLE | 1,302,645 | 0 | 0 | |||
Insmed Inc | COM PAR $.01 | 457669307 | 2,713,000 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | ||
Inspire Med Sys Inc | COM | 457730109 | 1,739,584 | 8,099 | SH | SOLE | 8,099 | 0 | 0 | |||
Insulet Corp | COM | 45784P101 | 37,742,794 | 220,203 | SH | SOLE | 220,203 | 0 | 0 | |||
Intuitive Surgical Inc | COM | 46120E602 | 56,223,799 | 140,880 | SH | SOLE | 140,880 | 0 | 0 | |||
Kura Oncology Inc | COM | 50127T109 | 10,706,380 | 501,940 | SH | SOLE | 501,940 | 0 | 0 | |||
Kyverna Therapeutics Inc | COM | 501976104 | 248,400 | 10,000 | SH | SOLE | 10,000 | 0 | 0 | |||
LivaNova PLC | SHS | G5509L101 | 1,144,309 | 20,456 | SH | SOLE | 20,456 | 0 | 0 | |||
Madrigal Pharmaceuticals Inc | COM | 558868105 | 5,081,504 | 19,029 | SH | SOLE | 19,029 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 12,665,519 | 1,401,053 | SH | SOLE | 1,401,053 | 0 | 0 | |||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 6,780,000 | 750,000 | SH | Call | SOLE | 750,000 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 946,488 | 104,700 | SH | Call | SOLE | 104,700 | 0 | 0 | ||
Marinus Pharmaceuticals Inc | COM | 56854Q200 | 9,040,000 | 1,000,000 | SH | Put | SOLE | 1,000,000 | 0 | 0 | ||
Masimo Corp | COM | 574795100 | 2,937,000 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | |||
Merck & Co Inc | COM | 58933Y105 | 85,938,903 | 651,299 | SH | SOLE | 651,299 | 0 | 0 | |||
Mirum Pharmaceuticals Inc | COM | 604749101 | 75,661 | 3,012 | SH | SOLE | 3,012 | 0 | 0 | |||
Novo-Nordisk A S | ADR | 670100205 | 78,565,906 | 611,884 | SH | SOLE | 611,884 | 0 | 0 | |||
PepGen Inc | COM | 713317105 | 7,403,273 | 503,624 | SH | SOLE | 503,624 | 0 | 0 | |||
Perspective Therapeutics Inc | COM | 46489V104 | 511,825 | 430,105 | SH | SOLE | 430,105 | 0 | 0 | |||
Pharvaris N V | COM | N69605108 | 13,511,770 | 584,672 | SH | SOLE | 584,672 | 0 | 0 | |||
Roivant Sciences Ltd | SHS | G76279101 | 10,557,960 | 1,001,704 | SH | SOLE | 1,001,704 | 0 | 0 | |||
Sarepta Therapeutics Inc | COM | 803607100 | 29,450,596 | 227,488 | SH | SOLE | 227,488 | 0 | 0 | |||
Savara Inc | COM | 805111101 | 11,689,360 | 2,347,261 | SH | SOLE | 2,347,261 | 0 | 0 | |||
Shockwave Med Inc | COM | 82489T104 | 11,397,050 | 35,000 | SH | SOLE | 35,000 | 0 | 0 | |||
Silk Rd Med Inc | COM | 82710M100 | 21,782,920 | 1,189,024 | SH | SOLE | 1,189,024 | 0 | 0 | |||
Soleno Therapeutics Inc | COM | 834203309 | 6,453,170 | 150,775 | SH | SOLE | 150,775 | 0 | 0 | |||
Spdr Ser Tr | S&P BIOTECH | 78464A870 | 80,656,500 | 850,000 | SH | Put | SOLE | 850,000 | 0 | 0 | ||
Structure Therapeutics Inc | SPONSORED ADS | 86366E106 | 374,296 | 8,733 | SH | SOLE | 8,733 | 0 | 0 | |||
Syndax Pharmaceuticals Inc | COM | 87164F105 | 38,283,252 | 1,608,540 | SH | SOLE | 1,608,540 | 0 | 0 | |||
Teleflex Incorporated | COM | 879369106 | 2,746,156 | 12,142 | SH | SOLE | 12,142 | 0 | 0 | |||
TG Therapeutics Inc | COM | 88322Q108 | 30,191,272 | 1,984,962 | SH | SOLE | 1,984,962 | 0 | 0 | |||
Aerovate Therapeutics Inc | COM | 008064107 | 111,144,345 | 3,758,686 | SH | SOLE | 3,758,686 | 0 | 0 | |||
Arrivent Biopharma Inc | COM | 04272N102 | 30,303,991 | 1,696,752 | SH | SOLE | 1,696,752 | 0 | 0 | |||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 113,987,017 | 754,032 | SH | SOLE | 754,032 | 0 | 0 | |||
Bolt Biotherapeutics Inc | COM | 097702104 | 3,856,212 | 2,754,437 | SH | SOLE | 2,754,437 | 0 | 0 | |||
Fusion Pharmaceuticals Inc | COM | 36118A100 | 2,496,551 | 117,099 | SH | SOLE | 117,099 | 0 | 0 | |||
Ikena Oncology Inc | COM | 45175G108 | 164,311 | 115,712 | SH | SOLE | 115,712 | 0 | 0 | |||
Inozyme Pharma Inc | COM | 45790W108 | 32,787,159 | 4,280,308 | SH | SOLE | 4,280,308 | 0 | 0 | |||
Natera Inc | COM | 632307104 | 141,788,609 | 1,550,280 | SH | SOLE | 1,550,280 | 0 | 0 | |||
Nextcure Inc | COM | 65343E108 | 5,958,239 | 2,671,856 | SH | SOLE | 2,671,856 | 0 | 0 | |||
Nucana PLC | SPONSORED ADR | 67022C106 | 884,192 | 3,400,739 | SH | SOLE | 3,400,739 | 0 | 0 | |||
Nucana PLC | COMMON SHARES | GB00BYWYV | 340,048 | 1,307,875 | SH | SOLE | 1,307,875 | 0 | 0 | |||
PDS Biotechnology Corp | COM | 70465T107 | 564,835 | 142,635 | SH | SOLE | 142,635 | 0 | 0 | |||
Vera Therapeutics Inc | CL A | 92337R101 | 120,476,719 | 2,793,987 | SH | SOLE | 2,793,987 | 0 | 0 | |||
Y-mAbs Therapeutics Inc | COM | 984241109 | 35,678,960 | 2,194,278 | SH | SOLE | 2,194,278 | 0 | 0 |